KEYNOTE-756 trial shows increased response in ER+/HER2- breast cancer

Neoadjuvant cemiplimab shows favourable event-free, disease-free and overall survival rates in patients with resectable CSCC

Where do we stand with mCRPC?

PARPi combinations to treat patients with mCRPC

Induction chemotherapy added to chemoradiation improves PFS and OS in advanced cervical cancer

Active surveillance for oesophageal cancer shows improved HRQoL compared to standard surgery

Sotorasib and panitumumab demonstrate clinically meaningful benefit in KRAS G12C-mutated metastatic colorectal cancer 

ESMO 2023: Latest in EGFR Ex20ins advanced NSCLC

Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC

McVie-Veronesi Awards: 2nd prize - Harnessing artificial intelligence to mitigate depression rates in cancer clinicians

McVie-Veronesi awards: Exploring the physical symptom burden in actively dying cancer patients.

McVie-Veronesi Awards: 3rd Prize - Role of sentinel lymph node biopsy in node positive breast cancer patients? Converting to node negativity after neoadjuvant chemotherapy